Platinum Equity acquires controlling stake in Inventia Healthcare Limited's core OSD business
Acquiring Company
Platinum Equity
Acquired Company
Inventia Healthcare Limited
Beverly Hills
MumbaiFinancial ServicesManufacturingBiotechnologyHealth CarePharmaceuticalDescription
Platinum Equity has announced the acquisition of a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business. The acquisition, led by Platinum Equity's Asia investment team, aims to leverage Inventia's strong foundation, expand its reach, and enhance its technology platform and delivery capabilities. This strategic move underscores Platinum Equity's commitment to driving innovation and growth in the pharmaceutical sector, particularly in emerging and underserved markets.
Quick answer
Platinum Equity is acquiring Inventia Healthcare Limited, announced August 31, 2024. Platinum Equity is based in Beverly Hills, California, United States.
- How much did Platinum Equity pay for Inventia Healthcare Limited?
- The deal value was not disclosed.
- What does Platinum Equity do?
- Founded in 1995 by Tom Gores, Platinum Equity is a global investment firm with more than $25 billion of assets under management and a portfolio of approximately 40 operating companies that serve customers around the..
- Where are Platinum Equity and Inventia Healthcare Limited based?
- Platinum Equity is based in Beverly Hills, California, United States. Inventia Healthcare Limited is based in Mumbai, Maharashtra, India.
- Who are the decision-makers at Platinum Equity?
- Fundz holds 1 contact at Platinum Equity. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix (July 24, 2024)
- Lupin strengthens its presence in the South African market through the acquisition of nine leading brands (October 4, 2024)
- Merck completes acquisition of investigational B-Cell depletion therapy, CN201, from Curon Biopharmaceutical (October 1, 2024)
- Breeze Holdings Acquisition Corp. to merge with YD Biopharma Limited to revolutionize cancer prevention diagnostics (September 25, 2024)
- Vitalograph acquires Morgan Scientific to strengthen US commercial footprint (September 23, 2024)
- Scantox Group finalizes acquisition of Gentronix Ltd, a UK-based genetic toxicology Contract Research Organization ("CRO") (September 9, 2024)
Who to call at Platinum Equity, and when
When Platinum Equity changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Platinum Equity raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Platinum Equity, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Platinum Equity. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Platinum Equity makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Inventia Healthcare Limited?
Inventia Healthcare Limited was acquired by Platinum Equity, based in Beverly Hills. The deal was reported on August 30, 2024. Platinum Equity is privately held and operates in Financial Services.
When did Platinum Equity acquire Inventia Healthcare Limited?
Platinum Equity's acquisition of Inventia Healthcare Limited was reported on August 30, 2024. Platinum Equity has announced the acquisition of a controlling stake in Inventia Healthcare Limited's core Oral Solid Dosage (OSD) business. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Inventia Healthcare Limited do?
Inventia Healthcare Limited is a well-established pharmaceutical company headquartered in Mumbai, India, with a strong global presence. It is privately held, operating in Manufacturing, and is based in Mumbai.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.